Amino acid variations of cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from fluconazole-resistant clinical isolates of Candida albicans

Revista Iberoamericana de Micologia

Volumn 16, Issue 4, 1999, Pages 198-203

  Manavathu, Elias K ^a   Kallakuri, Srinivasu ^a   Arganoza, María T ^a   Vázquez, Jose A ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

C. albicans; Demethylase; Fluconazole; Resistance

Indexed keywords

AMINO ACID; AMPHOTERICIN B; CYTOCHROME P450 ISOENZYME; FLUCONAZOLE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CROSS RESISTANCE; GENE SEQUENCE; NONHUMAN; PROTEIN EXPRESSION;

EID: 0033369251     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bailey GG, Perry FM, Denning DW, et al. Fluconazole resistant candidosis in an HIV cohort. AIDS 1994, 8:787-792.
2. Boscott PE, Grant GH Modelling cytochrome P450 14α-demethylase (Candida albicans) from P450CAM. J Mol Graphics 1994; 12: 185-192.
3. Cryer DR, Eccleshal R, Marmur J. Isolation of Yeast DNA. Method Cell Biol 1975; 12:39-44.
4. Drobacheff C, Manteaux A, Millpn E, et al. Fluconazple-resistant oral candidiasis in HIV positive patients. Ann Dermatol Venereol 1996, 123:85-89.
5. Espinel-Ingroff A, Kish CS, Kerkering TM, et al. Collaborative comparison of macrodilution and microdilution antifungal susceptibility tests. J Clin Microb 1992; 30:3138-3145.
6. He X, Tiballi RN, Zarins LT, Bradley SF, Sangeorzan JA, Kauffman CA. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1994; 38:2495-2497.
7. Heald AE, Cox GM, Schell WA, et al. Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy AIDS 1996; 10:263-268.
8. Hitchcock CA. Resistance of Candida albicans to azole antifungal agents. Biochem Soc Trans 1993; 21 1039-1047.
9. Hitchcock CA, Pye GW, Troke PF, et al. Fluconazole resistance in Candida glabrata. Antimicrob Agents Chemother 1993; 37:1962-1965.
10. Lai MH, Kirsch DR. Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 α-demethylase) from Candida albicans. Nucleic Acid Res 1989;17:804.
11. Loffler J, Kelly SL, Hebart H, Schumacher U, Lass-Flort C, Einsele H. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains. FEMS Microbiol Lett 1997;151:263-268
12. Manavathu EK, Kallakuri S, Arganoza MT, Pierson C, Vazquez JA Amino acid variations of cytochrome P450-dependent lanosterol 14α-demethylase (P450LDM) from fluconazole-resistant clinical isolates of Candida albicans. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents Chemotherapy, New Orleans, 1996, Abstract C68.
13. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast; Approved Standard NCCLS Document M27-A, NCCLS, Wayne, PA, 1997
14. Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. Clin Infect Dis 1994; 19:684-686.
15. Parkinson T, Falconer DJ, Hitchcock CA. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob Agents Chemother 1995; 39: 1696-1699.
16. Qiagen Plasmid Handbook. Midi/Maxi Plasmid/Cosmid Purification Protocol, 1995: 15-17
17. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: Documentation by in vitro susceptibility testing and DNA subtype analysis Clin Infect Dis 1994; 18:240-242
18. Rex JH, Rinaldi MG, Pfaller MA Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995,39:1-8.
19. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Nat Acad Sci USA 1977; 74: 5463-5467.
20. Sanglard D, Ischer F, Monod M, Bille J Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters Antimicrob Agents Chemother 1995; 39:2378-2386.
21. Sanglard D, Ischer F, Monod M, Bille J. Susceptibility of Candida albicans multidrug transporter mutants to different antifungal agents. ASM Conference on Candida and Candidiasis, San Diego, 1996, Abstract B33
22. Sanglard D, Ischer F, Monod M, Bille J Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996; 40: 2300-2305.
23. Sanglard D, Majcherczyk P, Ischer F, Bille J A rapid colorometric method for the study of resistance mechanisms to azole antifungal agents on yeasts. Clin Microbiol Infect 1997; 3 (Suppl 2):S83.
24. Sanglard D, Ischer F, Koymans L, Bille J Amino acid substitutions in the Cytochrorne P-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 1998,42:241-253.
25. Vanden Bossche H, Marichal P, Odds FC, et al. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992; 36:2602-2610.
26. Venkateswarlu K, Denning DW, Manning NJ Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug FEMS Microbiol Lettr 1995, 131: 337-341.
27. White A, Goetz MB. Azole-resistant Candida albicans: Report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994; 19.687-692
28. White TC The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α-demethylase in Candida albicans. Antimicrob Agents Chemother 1997; 41:1488-1494
29. White TC. Increased mRNA levels of ERG16, CDR, MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with Human Immunodeficiency Virus. Antimicrob Agents Chemother 1997; 41:1482-1487
30. Yoshida Y, Aoyama Y. Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes Biochem Pharmacol 1987, 36:229-235.